Susan Hasty, Publisher
Table of Contents . . . May 27th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Food and Drug Law Weekly | Other Publications
AMTSystems - Identification device for surgical safety introduced in healthcare industry
Adeza - Test assesses risk of preterm birth
Adventrx Pharmaceuticals, Inc. - U.S. FDA grants clearance for CoFactor phase III trial in colorectal cancer
Alcon, Inc. - New intraocular lens launched
BioAlliance Pharma - U.S. FDA grants orphan drug designation for doxorubicin Transdrug
Cellegy Pharmaceuticals, Inc. - Pharmaceutical firm responds to U.S. FDA inquiries about Cellegesic
Cook Biotech, Inc. - FDA clears Surgisis AFP Fistula Plug for fistula repair
Cordis Corporation - FDA grants approval of MRI immediately after stent implantation
Dade Behring - Company submits 510k for its Dimension Vista 1500 Analyzer
Exelixis, Inc. - Company files IND application for anticancer compound XL820
GlaxoSmithKline - Agreement reached on consent decree re Cidra, Puerto Rico, manufacturing site
Northwestern University, Chicago - Monitoring program finds serious, unreported adverse drug reactions
Paradigm Medical Industries, Inc. - 510k filed with FDA for ultrasound biomicroscope, company financials reported
Perrigo Company - Over-the-counter pharmaceutical company announces approval for Naproxen tablets
Prestwick Pharmaceuticals, Inc. - Pharma company submits NDA to U.S. FDA to market tetrabenazine
Adverse Drug Reaction - Nearly half of patients have lapses in doctors' office drug monitoring
Ariad Pharmaceuticals, Inc. - Patient enrollment begins in two trials of AP23573
Baylor College of Medicine, Houston - Recent findings in head and neck cancer provide new insights
Baylor College of Medicine, Houston - The PDX-1 gene is an early marker for a variety of human cancers
Baylor Institute Immunology Research - Dendritic cells as therapeutic cancer vaccines reviewed
Bioject Medical Technologies, Inc. - Medical device firm reports product sales increase of 42.9%
Boston University - Apolipoprotein A-I deletions corrupt lipid metabolism in study models
Botaniex, Inc. - Manufacturer of botanical extracts appoints chief operating officer
Bristol-Myers Squibb Company - Pharmaceutical firm reports 1Q results in line with expectations
CHU de Poitiers - Integra artificial skin can be used to reconstruct large defects
CancerVax Corporation - Anti-angiogenesis monoclonal antibody inhibits tumor growth
Catholic University of Daegu - Novel reverse micellar technique effective for PLGA microsphere loading
Catholic University of Louvain - Insulin-like growth factor-I gene transfer prevents steroid-induced atrophy
Celera Genomics Group - Data characterizes human histone deacetylase as cancer therapeutic
Cell Genesys, Inc. - Potential breakthrough reported in antibody production technology
Cephalon, Inc. - Company announces positive phase III results for ORAVESCENT fentanyl
Chiba University - Proteome-based identification of molecular markers predicted chemosensitivity
Children's Hospital, Boston - Strategies for prevention and management reviewed
Chonbuk National University Medical School - Genes involved in fenretinide-induced apoptosis identified
Chugai Pharmaceutical Co. Ltd, Shizuoka - Bivalent single-chain antibody fragments induce apoptosis in myeloma cells
Chung Hwa College of Medical Technology, Tainan - Phosphorylated and hypoacetylated mutant p53 enhanced apoptosis
Cincinnati Children's Hospital - Researchers' findings advance trichomoniasis research
Ciphergen Biosystems, Inc. - Agreement signed to evaluate proteomic system for ovarian cancer diagnostics
Columbia University, New York City - Variation in immune response gene causes eye disease when triggered
Commonwealth Biotechnologies, Inc. - Assay work delayed since 3Q 2004 begins
Congestive Heart Failure - New GP contract may not improve treatment for heart failure patients
Copenhagen University - Milk thistle does not reduce deaths from liver diseases
Cordis Corporation - Trial begun to evaluate stent technologies versus balloon angioplasty for PAD
Cornell University, New York - High expression of interferon-induced genes associated with disease severity
Curacyte AG - Drug discovery firm names David Ebsworth as chairman of supervisory board
Dalhousie University - G protein vaccine against RSV modulates protective immunity
Durham VA Medical Center - Understanding of HT risks, benefits associated with initial and continued use
Eli Lilly & Co. - Findings describe new data in osteoporosis research
Elite Pharmaceuticals, Inc. - IND filing for abuse-resistant technology for narcotic analgesics announced
Emory University - Senescence of the immune system is a risk factor for rheumatoid arthritis
Enzo Biochem, Inc. - Company reports data on laboratory studies at European Liver Conference
ExonHit Therapeutics - Company wins patent related to detection of mRNAs
Favrille, Inc. - Immunotherapy company reports first-quarter net loss of $8.4 million
Federal University of Rio De Janeiro - Multidrug resistance protein 1 expressed in murine thymoma cell line
Finance - Kindred Healthcare announces first quarter financial results
Forest Laboratories, Inc. - Campral is safe, well-tolerated in long-term treatment of alcohol dependence
Hamilton General Hospital - Studying gene-environment interaction across heterogeneous groups is recommended
National Institute Infection Diseases, Tokyo - ELISA system is a promising technique for fast diagnosis of Marburg virus
Sanguine Corp. - Biopharmaceutical company provides research update for shareholders
St. Jude Children's Research Center - Giving children access to drug trials is crucial, clofarabine approval shows
Teva Pharmaceutical Industries Ltd. - Pharmaceutical company gets U.S. FDA approval of antipsychotic generic drug
U.S. Centers for Disease Control & Prevention - Epidemiology of E. coli O157:H7 outbreaks in U.S. reported
U.S. Food & Drug Administration - Permeability of coenzyme Q10 in rat gastrointestinal tracts located
U.S. Food & Drug Administration - Re-use of ion chromatography media does not decrease virus removal
University of Michigan - Clot drug still meets resistance from doctors wary of its risks
University of Toronto - Healthcare ethics practical, smart, claims U of T study
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.